Jan Disbergen

Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA.

Blaze Bioscience, Inc. develops tumor paint products and Optide-based guided therapeutics for cancer patients. The firm provides BLZ-100. The company was founded by James M. Olson in 2010 and is headquartered in Seattle, WA.

Synvolux Therapeutics BV provides drug delivery services. It is specialized in transporting of DNA, RNA (siRNA and RNAi) and proteins to the target destination. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.

A.T. Kearney BV operates as a management consulting firm. The firm offers services that cover manufacturing, strategy, supply chain management, marketing, sales, as well as mergers and acquisitions. It serves industries that include aerospace, defence, automotive, financial institutions, pharmaceutical, health care and utilities. The company is headquartered in Amsterdam, the Netherlands.

NV NOM (NV NOM) is a private equity firm founded in 1974. The firm is headquartered in Groningen, Netherlands.

Organ Assist BV engages in the development of a medical device for organ preservation. It offers kidney assist transport, and donor, liver, lung, and kidney assist. The company was founded by Gerhard Rakhorst in 2005 and is headquartered in Groningen, the Netherlands.

Catalyst Advisors BV provides financial advisory services. Is activities include financial, transaction advisory and transactions. The company was founded by Joseph Krant and Herman van Everdingen in March 2003 and is headquartered in Amsterdam, the Netherlands.

Part of Novo Nordisk A/S, Novo Nordisk Pharmaceutical Industries, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Clayton, NC.

ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands.

ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands.

Synthon Holding BV engages in the research and production of therapeutic products. It offers remedies for cold sores, anaesthetic, hypertension, depression, neutralizing narcosis, insomnia, schizophrenia, heart failure and incontinence. The company was founded by Jacques Lemmens in 1991 and is headquartered in Nijmegen, Netherlands.

Medichem SA is a vertically Spanish integrated pharmaceutical company that specializes in the development and manufacture of APIs and FDFs for the generics market. The company is based in Sant Joan Despi, Spain, and has subsidiaries in Spain. The company offers highly potent active pharmaceutical ingredients (HPAPI) manufacturing, from development to cGMP production, and have an R & D laboratory and GMP kilo-lab. Medichem offers specific chlorhexidine transparent aqueous and alcoholic solutions based on chlorhexidine digluconate as an active ingredient, with a wide range of applications such as pharma, biocide, oral care, cosmetics, and veterinary. The company's chlorhexidine wipes are used for general disinfection. The company was founded in 1972, and José Luis Rodríguez has been the CEO of the company since 1996.

Vivolta BV is a world leader in the development and manufacturing of electrospun medical products. Vivolta is based in Waalre, Netherlands. The Dutch company utilizes its proprietary, fully automated medispin™ production platform to support its clients in realizing electrospun medical solutions that guide the body to heal itself. Vivolta’s medical electrospinning solutions are applicable to a broad array of high-value therapeutic areas with unmet clinical need, such as cardiovascular implants, soft tissue repair, orthopaedic sports medicine, and drug delivery. The company was founded in 2008 by Ramon Solberg, who has been the CEO since then.

VitalneXt BV develops retails and manufactures products for healthy ageing. Its products include promanna, vital01 and other products. The firm develops products with evidence-based health benefits for the ageing population. It also develops new, proprietary, technologies, ingredients and products through its own network and through collaborations with the company's research partners. The company was founded by Rein Strijker in May 2013 and is headquartered in Amersfoort, the Netherlands.

Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021.

Nutrileads BV develops food ingredi?nts with a specific nutritional value. It identifies promising lead ingredients, develops sustainable and commercially viable production processes and initiates scientific and clinical programs to test the health effects. The company was founded in 2012 by Erik Dam and Ruud Albers and is headquartered in Wageningen, the Netherlands.

ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.